Related Experiment Video
Updated: Jul 2, 2026
06:33
Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
Hypnosis, hypnotizability and treatment
The American Journal of Clinical Hypnosis
|August 22, 2008
Summary
Hypnosis is widely accepted, but its definition and mechanisms remain unclear. Despite varying hypnotizability levels, all patients in a 45-year study benefited from hypnosis, suggesting assessment irrelevance in clinical practice.
Area of Science:
- Psychology
- Medicine
- Dentistry
Background:
- Hypnosis is a recognized phenomenon, yet lacks a universal definition.
- Its historical use in healing practices has led to its current integration in medicine, psychiatry, psychology, and dentistry.
- The underlying mechanisms of hypnosis and its distinction from other cognitive states are poorly understood.
Purpose of the Study:
- To explore the clinical relevance of hypnotizability assessment.
- To investigate the effectiveness of hypnosis in diverse patient populations.
- To challenge the traditional reliance on hypnotizability scales in clinical hypnosis.
Main Methods:
- Retrospective analysis of four case studies from a 45-year clinical practice.
- Observation of patient responses to hypnosis across varying hypnotizability levels.
- Qualitative assessment of clinical outcomes in patients undergoing hypnosis.
Main Results:
- Hypnotizability assessment proved irrelevant in predicting clinical outcomes for the studied patients.
- Despite significant differences in hypnotizability, all four patients experienced benefits from hypnosis.
- Traditional or modern hypnotizability assessments did not guide the clinical application or outcomes.
Conclusions:
- Clinical hypnosis can be effective regardless of a patient's hypnotizability score.
- The focus on hypnotizability assessment may be misplaced in clinical settings.
- Further research is needed to understand the mechanisms of hypnosis and its effective application beyond standardized assessments.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Related Concept Videos
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:06Altered States of Awareness
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...